Document
type: Class

14311858
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study

Academic Article
type: Class

RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
related by: 14311864
type: Article
type: Document
related by: 14311858
type: Thing
type: Information Content Entity
type: Academic Article
type: Entity
type: Generically Dependent Continuant
language: Inglese
most specific type: Academic Article
type: Continuant

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

Article
type: Class

RDF description of RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study - http://irises.unilink.it/resource/item/57167
rights: termsOfUse
date: 2026-08-24T04:13:22
publisher: RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study
type: Document

Information Content Entity
type: Class

Inglese
type: Language

14311864
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study